Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jakesz

Showing results (161-170 of 185) with videos related to

Pageof 19
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Austrian Breast Cancer Study GroupR Jakesz, H Samonigg, M Gnant, et al.
Breast (Edinburgh, Scotland)|March 27, 2007
The use of a breast symmetry index for objective evaluation of breast cosmesisF Fitzal, W Krois, H Trischler, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cellsT Bachleitner-Hofmann, A Stift, J Friedl, et al.
British Journal of Cancer|July 9, 2014
The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancerR Exner, Z Bago-Horvath, R Bartsch, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients. Austrian Breast Cancer Study GroupE Kucera, P Speiser, M Gnant, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?G J Locker, G G Steger, M F Gnant, et al.
British Journal of Cancer|April 28, 2005
A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancerW Schippinger, M Jagoditsch, C Sorré, et al.
Acta Oncologica (Stockholm, Sweden)|February 7, 2001
Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patientsH T Greinix, W Linkesch, M Seifert, et al.
British Journal of Cancer|March 24, 2005
Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II)J Widder, F Herbst, W Dobrowsky, et al.
British Journal of Cancer|July 23, 2013
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trialM Gnant, G Pfeiler, H Stöger, et al.
Pageof 19

Showing results (161-170 of 185) with videos related to

Sort By:
Pageof 19
European Journal of Cancer (Oxford, England : 1990)|June 13, 1998
Very low-dose adjuvant chemotherapy in steroid receptor negative stage I breast cancer patients. Austrian Breast Cancer Study GroupR Jakesz, H Samonigg, M Gnant, et al.
Breast (Edinburgh, Scotland)|March 27, 2007
The use of a breast symmetry index for objective evaluation of breast cosmesisF Fitzal, W Krois, H Trischler, et al.
The Journal of Clinical Endocrinology and Metabolism|March 13, 2002
Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cellsT Bachleitner-Hofmann, A Stift, J Friedl, et al.
British Journal of Cancer|July 9, 2014
The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancerR Exner, Z Bago-Horvath, R Bartsch, et al.
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients. Austrian Breast Cancer Study GroupE Kucera, P Speiser, M Gnant, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 30, 1999
Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?G J Locker, G G Steger, M F Gnant, et al.
British Journal of Cancer|April 28, 2005
A prospective randomised trial to study the role of levamisole and interferon alfa in an adjuvant therapy with 5-FU for stage III colon cancerW Schippinger, M Jagoditsch, C Sorré, et al.
Acta Oncologica (Stockholm, Sweden)|February 7, 2001
Paclitaxel-containing high-dose chemotherapy in high-risk breast cancer patientsH T Greinix, W Linkesch, M Seifert, et al.
British Journal of Cancer|March 24, 2005
Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II)J Widder, F Herbst, W Dobrowsky, et al.
British Journal of Cancer|July 23, 2013
The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trialM Gnant, G Pfeiler, H Stöger, et al.
Pageof 19